ArticleWorld journal of surgical oncology2023

De-escalating chemotherapy for stage I-II gastric neuroendocrine carcinoma? A real-world competing risk analysis.

Danwei Du et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.